Ring Therapeutics Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
47
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$86.5M
- Investors
-
10
Ring Therapeutics General Information
Description
Developer of medical gene therapeutics designed to be incorporated through a novel viral vector platform. The company's platform aims to expand the applications of DNA-based treatments beyond gene replacement while targeting sites of disease with cellular and tissue specificity including genetic disorders, ophthalmology, oncology, and metabolic disorders among others, enabling healthcare companies to provide therapeutics as per the specific diseases using a much wider array of modalities and mechanisms.
Contact Information
Website
www.ringtx.comCorporate Office
- 620 Memorial Drive
- Suite 300
- Cambridge, MA 02141
- United States
Corporate Office
- 620 Memorial Drive
- Suite 300
- Cambridge, MA 02141
- United States
Ring Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series C) | 09-Mar-2023 | $86.5M | Completed | Generating Revenue | ||
| 3. Early Stage VC (Series B) | 28-Jul-2021 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 10-Dec-2019 | $50M | $50M | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | Completed | Generating Revenue |
Ring Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A1 | 7,063,260 | $0.001000 | $2 | $2 | 1x | $2 | 10.8% | |
| Series A | 11,017,231 | $0.001000 | $1 | $1 | 1x | $1 | 16.85% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Ring Therapeutics Comparisons
Industry
Financing
Details
Ring Therapeutics Competitors (45)
One of Ring Therapeutics’s 45 competitors is Annexon Biosciences, a Formerly VC-backed company based in Brisbane, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Annexon Biosciences | Formerly VC-backed | Brisbane, CA | ||||
| Minoryx | Venture Capital-Backed | Barcelona, Spain | ||||
| Kriya Therapeutics | Venture Capital-Backed | Morrisville, NC | ||||
| Prevail Therapeutics | Formerly VC-backed | New York, NY | ||||
| Sana Biotechnology | Formerly VC-backed | Seattle, WA |
Ring Therapeutics Patents
Ring Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230227849-A1 | Methods of identifying and characterizing anelloviruses and uses thereof | Pending | 17-Jun-2020 | ||
| US-11166996-B2 | Anellovirus compositions and methods of use | Active | 12-Dec-2018 | ||
| US-11446344-B1 | Anellovirus compositions and methods of use | Active | 12-Dec-2018 | ||
| US-20200188456-A1 | Anellovirus compositions and methods of use | Active | 12-Dec-2018 | ||
| US-20220362315-A1 | Anellovirus compositions and methods of use | Inactive | 12-Dec-2018 | C12N15/111 |
Ring Therapeutics Signals
Ring Therapeutics Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alexandria Venture Investments | Venture Capital | Minority | ||
| CJ Investment | Corporate Venture Capital | Minority | ||
| Kyowa Kirin | Corporation | Minority | ||
| Altitude Life Science Ventures | Venture Capital | Minority | ||
| Invus (Private Equity) | PE/Buyout | Minority |
Ring Therapeutics FAQs
-
When was Ring Therapeutics founded?
Ring Therapeutics was founded in 2017.
-
Where is Ring Therapeutics headquartered?
Ring Therapeutics is headquartered in Cambridge, MA.
-
What is the size of Ring Therapeutics?
Ring Therapeutics has 47 total employees.
-
What industry is Ring Therapeutics in?
Ring Therapeutics’s primary industry is Drug Discovery.
-
Is Ring Therapeutics a private or public company?
Ring Therapeutics is a Private company.
-
What is the current valuation of Ring Therapeutics?
The current valuation of Ring Therapeutics is .
-
What is Ring Therapeutics’s current revenue?
The current revenue for Ring Therapeutics is .
-
How much funding has Ring Therapeutics raised over time?
Ring Therapeutics has raised $254M.
-
Who are Ring Therapeutics’s investors?
Alexandria Venture Investments, CJ Investment, Kyowa Kirin, Altitude Life Science Ventures, and Invus (Private Equity) are 5 of 10 investors who have invested in Ring Therapeutics.
-
Who are Ring Therapeutics’s competitors?
Annexon Biosciences, Minoryx, Kriya Therapeutics, Prevail Therapeutics, and Sana Biotechnology are some of the 45 competitors of Ring Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process